Bnp Paribas »

Madrigal Pharmaceuticals shares owned by Bnp Paribas

Quarter-by-quarter ownership of Madrigal Pharmaceuticals (MDGL) shares owned by Bnp Paribas from 13F filings

Historical chart of Bnp Paribas investment in Madrigal Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Madrigal Pharmaceuticals held by Bnp Paribas consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Madrigal Pharmaceuticals by Bnp Paribas

Quarter filed Position value Share count Share price at filing
2024-03-31 $68k 255 267.04

More positions owned by Bnp Paribas

Microsoft Corp Equities (MSFT)
iShares iBoxx $ Investment Grade Corporate Bond ETF Fund (LQD)
Invesco Senior Loan ETF Fund (BKLN)
Apple Equities (AAPL)
Nvidia Corporation Equities (NVDA)
Amazon Equities (AMZN)
Salesforce Equities (CRM)
Alphabet Inc Cap Stk Cl C Equities (GOOG)
Visa Inc Com Cl A Equities (V)
Jpmorgan Chase & Co Equities (JPM)
Applied Matls Equities (AMAT)
Merck & Co Equities (MRK)
Disney Walt Equities (DIS)
Palo Alto Networks Equities (PANW)
Broadcom Equities (AVGO)

View all positions for Bnp Paribas

Top funds holding Madrigal Pharmaceuticals

Henderson Group
Baker Bros. Advisors
venBio Select Advisor
Paulson & Co
Vanguard Group
BlackRock
T. Rowe Price Associates
Susquehanna International
FMR
Perceptive Advisors
Artisan Partners Limited Partnership
Geode Capital Management
Alliancebernstein
Morgan Stanley
Rock Springs Capital Management

View all funds holding Madrigal Pharmaceuticals